Teriflunomide for multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Teriflunomide for Multiple Sclerosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436761/all/Face‐to‐face_versus_remote_and_web_2_0_interventions_for_promoting_physical_activity_New. Accessed 19 April 2024.
Teriflunomide for multiple sclerosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436761/all/Face‐to‐face_versus_remote_and_web_2_0_interventions_for_promoting_physical_activity_New. Accessed April 19, 2024.
Teriflunomide for multiple sclerosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436761/all/Face‐to‐face_versus_remote_and_web_2_0_interventions_for_promoting_physical_activity_New
Teriflunomide for Multiple Sclerosis [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436761/all/Face‐to‐face_versus_remote_and_web_2_0_interventions_for_promoting_physical_activity_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Teriflunomide for multiple sclerosis
ID - 436761
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436761/all/Face‐to‐face_versus_remote_and_web_2_0_interventions_for_promoting_physical_activity_New
DB - Evidence Central
DP - Unbound Medicine
ER -